Radiodermatitis: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Radiodermatitis
| Autor: | Pamela K. Ginex, Susan D. Bruce, Lauren V. Suarez, Chelsea Backler |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Side effect business.industry medicine.medical_treatment food and beverages Cancer medicine.disease Dermatology Cancer treatment Radiation therapy Quality of life Treatment interruption Neoplasms Quality of Life medicine Humans General Earth and Planetary Sciences Itching Radiodermatitis medicine.symptom business Skin General Environmental Science |
| Zdroj: | Clinical Journal of Oncology Nursing. 24:681-684 |
| ISSN: | 1538-067X 1092-1095 |
| DOI: | 10.1188/20.cjon.681-684 |
| Popis: | Approximately 50%-70% of patients with cancer will receive radiation therapy. Radiodermatitis is one of the most common side effects of radiation therapy, with as many as 95% of patients experiencing some degree of skin change. Radiodermatitis can cause pain, itching, and burning and potentially has a significant impact on a patient's quality of life. If radiodermatitis becomes severe, it can cause treatment interruption. The prevalence of radiodermatitis coupled with the effect this side effect can have on quality of life prompts the need for evidence-based recommendations for management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|